Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Conserved oligomeric Golgi complex subunit 4 (COG4) is a protein subunit of the conserved oligomeric Golgi (COG) complex, a crucial multiprotein machinery required for maintaining structure and intracellular function of the Golgi apparatus. The COG complex is essential for correct protein glycosylation and vesicle tethering, mediating the retrograde transport of proteins and lipids from the Golgi apparatus back to the endoplasmic reticulum. COG4 provides important structural and tethering functions within the COG complex, ensuring proper modification and sorting of glycoproteins and other cargo critical to normal cellular operations. Mutations in COG4 disrupt glycosylation pathways, causing congenital disorders such as congenital disorder of glycosylation (COG4-CDG) and Saul-Wilson syndrome, which are characterized by developmental delays, intellectual disability, skeletal and growth abnormalities, and other severe systemic manifestations. There are no known small molecule drugs or therapeutic biologics clinically targeting COG4.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Conserved oligomeric Golgi complex subunit 4 (COG4).